Cargando…
Modulation of Receptor Tyrosine Kinase Activity through Alternative Splicing of Ligands and Receptors in the VEGF-A/VEGFR Axis
Vascular endothelial growth factor A (VEGF-A) signaling is essential for physiological and pathological angiogenesis. Alternative splicing of the VEGF-A pre-mRNA gives rise to a pro-angiogenic family of isoforms with a differing number of amino acids (VEGF-A(xxx)a), as well as a family of isoforms w...
Autores principales: | Stevens, Megan, Oltean, Sebastian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6523102/ https://www.ncbi.nlm.nih.gov/pubmed/30925751 http://dx.doi.org/10.3390/cells8040288 |
Ejemplares similares
-
Modulation of VEGF-A Alternative Splicing as a Novel Treatment in Chronic Kidney Disease
por: Stevens, Megan, et al.
Publicado: (2018) -
Modulation of the Apoptosis Gene Bcl-x Function Through Alternative Splicing
por: Stevens, Megan, et al.
Publicado: (2019) -
Antitumour efficacy of VEGFR2 tyrosine kinase inhibitor correlates with expression of VEGF and its receptor VEGFR2 in tumour models
por: Dev, I K, et al.
Publicado: (2004) -
SRPK1 inhibition in prostate cancer: A novel anti-angiogenic treatment through modulation of VEGF alternative splicing
por: Mavrou, Athina, et al.
Publicado: (2016) -
Pharmacology of Modulators of Alternative Splicing
por: Bates, David O., et al.
Publicado: (2017)